Search
for
Sort by
Research 391–420 of 1000+
- Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population
- Emerging role of baricitinib in dermatology practice: All we need to know!
- Folliculitis decalvans responsive to tofacitinib: A case series
- Two phase III trials of baricitinib for alopecia areata: a critically appraised research paper
- Relapse of Alopecia Areata Responders After Tofacitinib Withdrawal: A Retrospective Study of 59 Patients
- SDRIFE Induced by Tofacitinib
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
- Alopecia areata-like hair loss after a tick bite
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- Oral Baricitinib Restores Hair Loss in Alopecia Areata
- Alopecia universalis. Partial response to tofacitinib
- 1313 Fzd2 controls multiple aspects of epidermal development through distinct signaling mechanisms
- Treatment of severe alopecia areata with oral tofacitinib: A case series
- Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib
- Upadacitinib for Severe Alopecia Areata in Adults and Adolescents
- Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?
- A Successful Treatment of Alopecia Universalis with Ruxolitinib
- Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials
- Long‐Term Real‐World Outcomes of Baricitinib in Severe Alopecia Areata: A 104‐Week Retrospective Analysis From a Single Institute
- Hair loss disorders (alopecias)
- Baricitinib-Induced Trichilemmal Cyst Reactivation in a Woman With Alopecia Areata
- Treatment Challenges in Alopecia Areata: Insights From a Case of Baricitinib Therapy Failure
- The Efficacy of Baricitinib as a Treatment Option for Alopecia, In Terms of Promoting Hair Regrowth and Improving Patient Reported Outcomes
- Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
- 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
- ISID1108 - Comparison of ruxolitinib and a collagen-targeted PTH-based hair cycle stimulant on hair follicle counts and hair growth in the C3H/HeJ engrafted mouse model of alopecia areata.
- A Promising Efficacy of Tofacitinib in an Adult Patient with Alopecia Areata
- Tofacitinib: A Promising Treatment for Adolescent Alopecia Areata